66. FIS highlights 2 - Neurosurgical infectio...

Now this an episode, first of a triple About all the work of a lab called RIPL And we'd like to take minute now so sit right here And learn about all the horrible pathogens you now should fear Register for the BIA Spring Meeting 2026 here! Support the showWe are currently seeking ...  Show more

Part 2 of 2 on Echinocandins! Tihana Bicanic gives a masterclass on Rezafungin, its use now and in the future, and gives an update on the relevant clinical trials and studies you need to know to make you a Master Echinocandologist. Alyssa and Jame are here too, but very much in r ...  Show more

Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

Inclisiran, sodium-channel blocker safety, analytic flexibility, the work-up of patients with HF, and BP in older patients are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.

To rea ...

Observational studies, another defense of digoxin, CTO-PCI, BP measurement, and a possible revolution in cardiovascular protection are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only. To read a p ...

An update in trial interpretation, CI, and P-values; percutaneous tricuspid Interventions; and news on HDL and humility in Medicine are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only</ ...